Intrinsiqq
Tectonic Therapeutic Inc. logo

Tectonic Therapeutic Inc. Insider Trading

TECX

Compare
Last 12 months

Insiders bought 182K and sold 651K on the open market.

All of the selling was scheduled in advance under 10b5-1 plans.

Net open-market
−469K
2 buys · 9 sales
Under a 10b5-1 plan
100%
of the value sold
Insiders who bought / sold
2 / 2
executives and directors
Last open-market buy
Feb 2026
Feb 11, 2026

Get an email when TECX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 3010b5-1 plan
    Peter McNamara
    Chief Scientific Officer · sold 536 at $23.04
    12K
    1.0% of stake
  • Aug 2510b5-1 plan
    Peter McNamara
    Chief Scientific Officer · sold 43 at $36.52
    2K
    <0.1% of stake
  • Aug 1210b5-1 plan
    Peter McNamara
    Chief Scientific Officer · sold 43 at $35.00
    2K
    <0.1% of stake
  • Jun 3010b5-1 plan
    Peter McNamara
    Chief Scientific Officer · sold 172 at $35.00
    6K
    0.3% of stake
  • May 410b5-1 plan
    Marcella K. Ruddy
    Chief Medical Officer · sold 1,065 at $30.00
    32K
    1.5% of stake
  • Apr 110b5-1 plan
    Marcella K. Ruddy
    Chief Medical Officer · sold 1,000 at $31.05
    31K
    1.4% of stake
  • Mar 610b5-1 plan
    Marcella K. Ruddy
    Chief Medical Officer · sold 10,000 at $30.00
    300K
    13% of stake
  • Mar 610b5-1 plan
    Peter McNamara
    Chief Scientific Officer · sold 6,262 at avg $30.17
    189K
    10% of stake
  • Mar 3 – 410b5-1 plan
    Peter McNamara
    Chief Scientific Officer · sold 3,299 at avg $23.53
    78K
    5.3% of stake
  • Feb 11
    Alise Reicin
    Chief Executive Officer · bought 2,500 at $21.10
    53K
    0.7% of stake
  • Feb 10
    Daniel Lochner
    Chief Financial Officer · bought 6,000 at $21.61
    130K
    23% of stake
  • Apr 9, 2025 – Apr 11, 2025
    Timothy A Springer
    Director · bought 141,923 at avg $16.20
    $2.3M
    2.4% of stake
  • Apr 7, 2025
    Timothy A Springer
    Director · bought 500,000 at avg $17.10
    $8.55M
    9.3% of stake
  • Apr 7, 2025No plan
    Terrance McGuire
    Director · sold 500,000 at $17.10
    $8.55M
    47% of stake
  • Feb 5, 2025
    Timothy A Springer
    Director · bought 789,294 at avg $50.68
    $40M
    17% of stake
  • Feb 5, 2025
    Daniel Lochner
    Chief Financial Officer · bought 4,617 at $54.14
    250K
    New position
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch TECX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with TECX

CompareIntrinsic value
RGNXRegenxbio Inc.
$7.16-0.28%36
ENTXEntera Bio Ltd.
$3.31+0.76%20
ATYRAtyr Pharma Inc.
$3.82+3.52%10
ELUTElutia Inc.
$0.89+8.54%20
AUTLAutolus Therapeutics plc
$0.91-7.45%40
IKTInhibikase Therapeutics Inc.
$1.31+0.38%10
HUMAHumacyte, Inc.
$0.45-17.97%0
PALIPalisade Bio Inc.
$0.84-9.69%20

Held by ETFs

TECX is in 10 US ETFs. The largest of them, with TECX's weight in each:

Spot a number that looks wrong? Check it in TECX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing TECX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.